Heron Therapeutics is trading 6.2% up at $0.50 in after-hours trading despite a lack of fresh company-specific news or fundamental catalysts.
- The move represents a rebound from a minor decline during the regular session, continuing a week characterized by high volatility.
- No new SEC filings, analyst reports, or headlines were released today, suggesting the price action is driven by trading dynamics rather than fundamental news.
- The strength in the stock comes against a backdrop of broader market weakness across major indices.